Progress in noninvasive assessment of cardiac amyloidosis

Amyloidosis is a group of disorders caused by misfolded proteins that deposit in tissues and impair the function of vital organs. Systemic amyloidosis frequently involves the heart and is a leading cause of death in affected patients. Cardiac amyloidosis is difficult to diagnose and carries a poor prognosis, making early diagnosis and assessment crucial for treatment and prognosis. This article reviews several noninvasive techniques for diagnosing and evaluating cardiac amyloidosis.